What does the ALK/NPM1: T(2;5) Translocation / Heparin Blood test include at Metropolis Healthcare?
The test detects the NPM-ALK fusion gene resulting from t(2;5) translocation using Metropolis Healthcare’s advanced molecular diagnostic methods.
How does Metropolis Healthcare perform the ALK/NPM1 Translocation test?
Metropolis Healthcare uses sensitive molecular techniques such as PCR or FISH with strict quality control to ensure precise and reliable results.
Who should take the ALK/NPM1: T(2;5) Translocation / Heparin Blood test at Metropolis Healthcare?
Patients suspected of anaplastic large cell lymphoma or related hematologic malignancies may be advised to take this test.
What sample is required for the ALK/NPM1 Translocation test at Metropolis Healthcare?
A heparinized blood sample collected by trained professionals at Metropolis Healthcare is required for testing.
How should I prepare for the ALK/NPM1: T(2;5) Translocation test at Metropolis Healthcare?
No special preparation is typically required, but Metropolis Healthcare provides instructions to ensure proper sample collection.
How long does it take to receive ALK/NPM1: T(2;5) Translocation results from Metropolis Healthcare?
Results are usually available within the standard molecular testing timeframe, with Metropolis Healthcare ensuring timely reporting.
What do abnormal ALK/NPM1: T(2;5) Translocation results indicate at Metropolis Healthcare?
Detection of the translocation confirms presence of the NPM-ALK fusion, aiding diagnosis, prognosis, and targeted therapy planning.
Can I consult a doctor about my ALK/NPM1: T(2;5) Translocation / Heparin Blood results at Metropolis Healthcare?
Yes, Metropolis Healthcare supports consultations to interpret results and guide appropriate management and treatment strategies.